METABOLIC INACTIVATION OF BLEOMYCIN ANALOGS BY BLEOMYCIN HYDROLASE

被引：23

作者：

SEBTI, SM

LAZO, JS

机构：

来源：

PHARMACOLOGY & THERAPEUTICS | 1988年 / 38卷 / 03期

关键词：

D O I：

10.1016/0163-7258(88)90009-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：321 / 329

页数：9

共 50 条

[1] TOTAL SYNTHESIS OF BLEOMYCIN [J].

AOYAGI, Y ;

KATANO, K ;

SUGUNA, H ;

PRIMEAU, J ;

CHANG, LH ;

HECHT, SM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (20) :5537-5538

[2] BLEOMYCIN [J].

BENNETT, JM ;

REICH, SD .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (06) :945-948

[3] DNA DAMAGE INDUCED BY BLEOMYCIN IN THE PRESENCE OF DIBUCAINE IS NOT PREDICTIVE OF CELL-GROWTH INHIBITION [J].

BERRY, DE ;

KILKUSKIE, RE ;

HECHT, SM .

BIOCHEMISTRY, 1985, 24 (13) :3214-3219

[4]

BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO

[5]

2-N

[6] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE [J].

BONADONNA, G ;

SANTORO, A .

CANCER TREATMENT REVIEWS, 1982, 9 (01) :21-35

[7] STIMULATION OF IRON(II) BLEOMYCIN ACTIVITY BY PHOSPHATE-CONTAINING COMPOUNDS [J].

BURGER, RM ;

HORWITZ, SB ;

PEISACH, J .

BIOCHEMISTRY, 1985, 24 (14) :3623-3629

[8] SEQUENCE SPECIFIC CLEAVAGE OF DNA BY ANTI-TUMOR ANTIBIOTICS NEOCARZINOSTATIN AND BLEOMYCIN [J].

DANDREA, AD ;

HASELTINE, WA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) :3608-3612

[9] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].

EINHORN, LH ;

DONOHUE, J .

ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298

[10]

EKOMOTO H, 1987, J CLIN BIOCH NUTR, V2, P25

← 1 2 3 4 5 →